Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-15,000
Closed -$208K 2981
2022
Q2
$208K Hold
15,000
﹤0.01% 2866
2022
Q1
$294K Sell
15,000
-2,000
-12% -$39.9K ﹤0.01% 2763
2021
Q4
$583K Buy
17,000
+5,500
+48% +$221K ﹤0.01% 2366
2021
Q3
$628K Sell
11,500
-2,500
-18% -$151K ﹤0.01% 2120
2021
Q2
$1.03M Buy
14,000
+12,000
+600% +$1.2M ﹤0.01% 1756
2021
Q1
$183K Buy
+2,000
New +$194K ﹤0.01% 2562

Other funds holding CVAC

HSBC Holdings's CVAC Position: Q4 2022 in Review

HSBC Holdings sold out of CureVac (CVAC) in Q4 2022, closing a stake of 52,961 shares — an estimated $418K sold.

HSBC Holdings first reported a position in CVAC in Q1 2021 and held it in 7 quarters. The position peaked at $1.48M in Q3 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q4 2022.

  • HSBC Holdings reported no remaining CureVac position as of Q4 2022 after selling out during the quarter.
  • HSBC Holdings sold 52,961 CureVac shares in Q4 2022, an estimated $418K.
  • HSBC Holdings first reported a position in CureVac in Q1 2021 and held it in 7 quarters.
  • HSBC Holdings's CureVac position peaked at $1.48M in Q3 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q4 2022.

Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.